Table 2 Baseline characteristics of the study sample
Age [years] | 77.0 ± 5.8 |
Female | 41.4 (12/29) |
Heart rate [bpm] | 74 ± 9 |
Systolic blood pressure [mmHg] | 119 ± 19 |
Diastolic blood pressure [mmHg] | 67 ± 14 |
Body mass index [kg/m2] | 25.8 ± 4.2 |
NT-proBNP [pg/ml] median(P25;75) | 3618 (1619; 5782) |
Serum creatinine [mg/dl] median(P25;75) | 1.1 (1.0; 1.6) |
logEuroScore [%] median(P25;75) | 18.5 (12.7; 32.2) |
NYHA functional class | |
I | 0 (0/29) |
II | 24.1 (7/29) |
III | 62.1 (18/29) |
IV | 13.8 (4/29) |
Comorbidities | |
DCM | 10.3 (3/29) |
Coronary artery disease | 62.1 (18/29) |
Diabetes mellitus II | 34.5 (10/29) |
Medical/Device treatment | |
High-ceiling diuretics | 100 (29/29) |
ACE inhibitors | 48.3 (14/29) |
MRA | 62.1 (18/29) |
Beta-blocker | 89.7 (26/29) |
CRT | 6.9 (2/29) |